Custo Med custo screen 300

Device Name:
custo screen 300
Manufacturer:
custo med GmbH, Maria-Merian-Straße 6, D-85521 Ottobrunn, GERMANY.
Measuring functions:
Blood pressure
Primary Client Use:
Intended for ambulatory blood pressure monitoring
Measurement Site:
Upper Arm
Measurement Occurrence:
Intermittent measurements at specified intervals or times
Availability:
Available Currently
Availability according to Countries or Regions:
Ireland
Device Manual:
Description:
The Custo Med custo screen 300 is an ambulatory blood pressure monitor. The accuracy of its blood pressure measurement technology has yet to be proven to MDR requirements. Blood pressure measurements are taken from the upper arm. It is intended for ambulatory blood pressure monitoring.
Assessment:
The technology used in the Custo Med custo screen 300, to measure blood pressure, has been compared to a clinically validated device, but the results of the equivalence study have not been published and cannot be verified; nor can the protocol be checked for compliance with (EU) 2017/745 and MEDDEV 2.7/1 rev 4.
Recommendations:
Accuracy Assessment | Recommendation | Basis | |
BP | Medaval | None | Although equivalence to another device is claimed, this has not been tested to MDR requirements. |
BP | Stride BP | ABPM for children (Preferred) | Equivalence to the Custo Med custo screen Pediatric claim without published evidence |
Device Family:
Custo Med custo screen 300P, Custo Med custo screen PediatricP, Custo Med custo screen 310P
Legend: P Stride Equivalence
Legend: P Stride Equivalence
Validation Publications for Equivalent Devices:
Note: This is a provisional list, as equivalence according to EU Regulation 2017/745 (e.g. MEDDEV 2.7/1 rev 4) is not proven. Accordingly, these publications are not used in the assessment of star-ratings.
Custo Med custo screen Pediatric
Beime B, Deutsch C, Krüger R, Wolf A, Müller P, Hammel G, Bramlage P. Validation of the custo screen pediatric blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Eur J Pediatr. 2017 May;176(5):573-80. Epub: 2017 Feb 24. doi: 10.1007/s00431-017-2874-3. PMID: 28236027.
ESH-IP:2010 - Pass Children, aged 3 to 12 years (n=33)